Denta Water Vs Rexpro Enterprises IPO- What’s a better IPO to subscribe?

The Indian IPO market is abuzz with activity, offering investors a mix of opportunities across mainstream and SME segments. Two ongoing IPOs – Denta Water and Rexpro Enterprises have caught the market’s attention.

Let’s take a look the key details of these two IPO such as GMP, subscription status, price and other key details

Denta Water IPO Vs Rexpro Enterprises IPO: GMP Update

GMPs often indicate the sentiment around an IPO. Denta Water IPO is trading at a premium of Rs 130, this suggests an estimated listing price of Rs 424 per share, 44.22% above its upper price band of Rs 294 per share.

Also ReadDenta Water IPO GMP drops 44% on Day 2: More on IPO allotment, subscription and other details

On the other hand, Rexpro Enterprises GMP stands at Rs 20, with an anticipated listing price of Rs 165 per share, offering a smaller upside of 13.79% over its upper price band of Rs 145.

“The company ranks among the top two dental laboratories in India by revenue and is the leading exporter of dental products. We believe that going forward company’s growth factor could be driven by trends such as the changing regulatory requirements in the medical devices sector helps transition from unorganized to organized players, increasing awareness and demand for dental aesthetics, and the growing preference for metalfree dental products. Hence considering all parameters, we recommend the issue can be consider as “SUBSCRIBE for LONG TERM”,” said Anand Rathi research firm in an IPO note.

Denta Water IPO Vs Rexpro Enterprises IPO: Key issue details

Both IPOs are currently in their second day of bidding and differ significantly in structure and size.

The Denta Water IPO is a mainboard, book-built issue with a total size of Rs 220.50 crores, entirely raised through a fresh issue.

Talking of the key players of the Denta Water issue, SMC Capitals is the book-running lead manager, while Integrated Registry Management Services acts as the registrar.

On the other hand, the Rexpro Enterprises IPO is an SME, fixed-price issue with a total size of Rs 53.65 crores. This includes a fresh issue of Rs 47.13 crores and an OFS of Rs 6.53 crores. The issue is managed by Horizon Management, with Cameo Corporate Services as the registrar and Giriraj Stock Broking is serving as the market maker.

 » Read More

Related Articles

Q3FY25 Results: Thyrocare reports 30 percent rise in profit; Revenue stood at Rs 165.9 Crore

Thyrocare on Thursday announced its financial results for the quarter and nine months ended December 31, 2024. According to the company’s statement, the diagnostics major reported revenue of Rs. 165.9 Cr in Q3FY25 with a growth of 23 percent YoY. According to the company’s statement, Thyrocare’s consolidated revenue increased by 23% year-over-year (YoY) with Pathology

Gold prices soar to new peak of Rs 82,900 per 10 gm; silver drops by Rs 500

Gold prices rose Rs 170 to hit a fresh record high of Rs 82,900 per 10 grams in the national capital on Thursday amid a positive global trend, according to the All India Sarafa Association. The precious metal had closed at Rs 82,730 per 10 grams on Wednesday. In about one year, the precious metal

Good news for taxpayers! Govt removes THESE difficulties to ensure more tax cases are settled – Check details!

Good news for taxpayers! The Finance Ministry has made some changes to the Direct Tax Vivad Se Vishwas Scheme, 2024, removing “difficulties” that arose due to certain situations for taxpayers. This update in the scheme will bring relief to taxpayers who wanted to apply for the scheme but could not do so earlier. “CBDT…makes the

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Q3FY25 Results: Thyrocare reports 30 percent rise in profit; Revenue stood at Rs 165.9 Crore

Thyrocare on Thursday announced its financial results for the quarter and nine months ended December 31, 2024. According to the company’s statement, the diagnostics major reported revenue of Rs. 165.9 Cr in Q3FY25 with a growth of 23 percent YoY. According to the company’s statement, Thyrocare’s consolidated revenue increased by 23% year-over-year (YoY) with Pathology

Gold prices soar to new peak of Rs 82,900 per 10 gm; silver drops by Rs 500

Gold prices rose Rs 170 to hit a fresh record high of Rs 82,900 per 10 grams in the national capital on Thursday amid a positive global trend, according to the All India Sarafa Association. The precious metal had closed at Rs 82,730 per 10 grams on Wednesday. In about one year, the precious metal

Good news for taxpayers! Govt removes THESE difficulties to ensure more tax cases are settled – Check details!

Good news for taxpayers! The Finance Ministry has made some changes to the Direct Tax Vivad Se Vishwas Scheme, 2024, removing “difficulties” that arose due to certain situations for taxpayers. This update in the scheme will bring relief to taxpayers who wanted to apply for the scheme but could not do so earlier. “CBDT…makes the

Johnnie Walker-maker United Spirits posts Q3 profit decline of 4.29% to Rs 335 crore, revenue up 11.06% YoY

United Spirits, which makes Smirnoff vodka, on Thursday reported a profit of Rs 335 crore for the third quarter of FY25, posting a decline of 4.29 per cent in comparison to Rs 350 crore during the corresponding quarter of previous financial year. It posted revenue from operations at Rs 7,732 crore, reporting a growth of

Q3FY25: Mankind Pharma’s revenue up by 24 percent to Rs 3,230 Crore; Profit at Rs 380 crore

Pharma major Mankind Pharma on Thursday reported its financial results for the third quarter and nine months ended 31 st December 2024. The company reported revenue from Operations at Rs. 3,230 Cr, up by 24% YoY and domestic revenue at INR 2,773 Cr, up 17%, Exports at INR 457 Cr, up 121% YoY. The company’s